Astrana Health (ASTH) 2013年年度报告「NASDAQ」.pdf

1、SECURITIES&EXCHANGE COMMISSION EDGAR FILINGForm:10-K Date Filed:2014-05-08Corporate Issuer CIK:1083446 Copyright 2014,Issuer Direct Corporation.All Right Reserved.Distribution of this document is strictly prohibited,subject to theterms of use.UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington

2、,D.C.20549 FORM 10-K(Mark One)x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D)OF THE SECURITIESEXCHANGE ACT OF 1934 For the fiscal year ended January 31,2014 o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)OF THE SECURITIESEXCHANGE ACT For the transition period from _ to _ Commission File No.000-2

3、5809 Apollo Medical Holdings,Inc.(Exact name of registrant as specified in its charter)Delaware20-8046599State of IncorporationIRS Employer Identification No.700 North Brand Blvd.,Suite 220Glendale,California 91203(Address of principal executive offices)(818)396-8050(Issuers telephone number)Securit

4、ies Registered Pursuant to Section 12(b)of the Act:Title of each Class Name of each Exchange on which Registered None Securities Registered Pursuant to Section 12(g)of the Act:Common Stock,$.001 Par Value Indicate by check mark if the registrant is a well-known seasoned issuer,as defined in Rule 405

5、 of the Securities ActYes No x Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d)of the Exchange Act.Yes Nox Check whether the issuer(1)filed all reports required to be filed by Section 13 or 15(d)of the Exchange Act during the past 12 mo

6、nths(or for such shorter period that the registrantwas required to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes x No Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website,if any,every interacti